Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth. Giving paclitaxel and carboplatin together with gefitinib may kill more
tumor cells.
PURPOSE: This phase II trial is studying the side effects of giving paclitaxel and
carboplatin together with gefitinib and to see how well it works in treating patients with
Stage IIIB or stage IV non-small cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences